Three of the most recognized experts on IP farma in Spain Ángel García Vidal, profesor de Derecho Mercantil de la Universidad de Santiago de Compostela y Consejero Académico de Gómez Acebo y Pombo, Kiko Carrión García de Parada, Abogado socio […]
Jorge Muñoz, Member of CEFI Board lead the debate on advanced therapies an biological medicinal products. Sol Ruíz, Jefe de División de Productos Biológicos, Terapias Avanzadas y Biotecnología de la Agencia Española de Medicamentos y Productos Sanitarios and Jordi Faus, […]
Interesting debate with Jesús Rubí, Adjunto a la Dirección de la Agencia Española de Protección de Datos, Amelia Martín Uranga, Responsable de la Plataforma de Medicamentos Innovadores de Farmaindustria and Lluis Alcover, Abogado de Faus y Moliner. Interestingf debate about main […]
With Javier Castrodeza, Ex Secretario General de Sanidad y Catedrático de Medicina Preventiva y Salud Pública, Lourdes Fraguas, Abogada of Cousel Herbert Smith Freehills Spain, César Hernández, Jefe del Departamento de Medicamentos de Uso Humano de la Agencia Española de […]
Katia Piñol Torres, our President and Patricia Lacruz. Directora General de Cartera Común de Servicios del Sistema Nacional de Salud y Farmacia del Ministerio de Sanidad at the opening of the course. Nice speakers and more tan 180 attendees.
Royal Decree 957/2020 As of 2 January 2021, observational studies of medicinal products for human use (‘OSM’) are to be regulated in Spain by Royal Decree 957/2020, which repeals the previously applicable Order SAS/3470/2009. The main purpose of Royal Decree […]
Section One. Current Affairs Medicine in the courts in 2020. Jordi Faus, Xavier Moliner, Eduard Rodellar, Santiago Tomás, Anna Gerbolés, Lluís Alcover, Laura Marquès, Juan Martínez, and Joan Carles Bailach Data protection in the COVID-19 pandemic (Part II). Jesús Rubí […]
There is an ongoing debate about certain national and international policy initiatives concerning the mandatory licensing of COVID-19 vaccine patents and we see the need to clarify certain concepts. In the event of mandatory licensing, it is more than likely […]
As we all know, on 1 January 2021 the new version of the Code of Practice for the Pharmaceutical Industry (the ‘new Code’ or, simply, the ‘Code’) came into force. As well as incorporating the amendments introduced in June 2019 […]
In light of the current COVID-19 health crisis, it is an apt moment to highlight the importance of intellectual property. Intellectual and industrial property, among others, allow us to turn ideas into concrete projects that create value, wealth, jobs, and […]
Interruption of supply or the withdrawal of medicines from the market and competition rules. Henar González Durántez y Pilar Carrasco del Olmo 2021 versión of Pharmaceutical Industry Code of Best Practices. Teresa Paz-Ares Rodríguez, Beatriz Cocina Arrieta y Nuria […]
Recent investigations of the pharmaceutical sector by the competition authorities demonstrate a focus on examining a number of actions that could entail an interruption of supply or even the withdrawal of medicinal products from the market by pharmaceutical companies. Specifically, […]
Page 6 of 9
A foundation for promoting and supporting research and technological development, especially regarding the pharmaceutical industry
Nuestra entidad se encuentra adherida a Confianza Online (Asociación sin ánimo de lucro), inscrita en el Registro Nacional de Asociaciones Grupo 1, Sección 1, número nacional 594400, CIF G85804011, Calle Carrera de San Jerónimo, 18 28014 Madrid (España).. Para más información: (confianzaonline.es).